Low — 0 expert voices in the Synthos KB, 0 traceable claims; the call rests entirely on data
Position sizing
Value/income satellite, ~1.5–3% — a rate-cycle and self-help holding, not a core compounder
Next catalyst
2026-07-16 Q2'26 earnings (Street EPS $1.27)
Single biggest risk
Rate-cycle & credit: a recession/CRE deterioration lifts loss provisions and compresses net interest margin
One-line thesis. USB is a cheap (~13× earnings, ~2× tangible book), A-rated super-regional bank throwing off a 3.4% dividend and a 17% return on tangible common equity, with a genuine self-help efficiency story (efficiency ratio 58.2%, 440bps of positive operating leverage in Q1'26) — a reasonable value/income buy where the upside is a re-rating plus mid-single-digit compounding, not exponential growth, and the honest gate is that no Synthos expert covers it.
◆ Synthos call — Buy — TacticalUSB offers ~10% upside to fair value (~$68) with the trend confirming — buy $56–$62, take profits toward $68, and exit on a close below the 200-day (~$53).
Downside Risk (lower = safer)
4/10 · Moderate
Cheap at ~13× and A- rated with 10.8% CET1, beta ~1.0 — but rate-cycle cyclicality and CRE/credit exposure cap safety.
Growth Quality
5/10 · Moderate
~11% forward EPS CAGR off a self-help efficiency story; 17% ROTCE, but low-single-digit revenue growth and a mature deposit franchise.
Exponential Potential
2/10 · Low
A $96B mature money-center bank — durable, not exponential; growth is steady-to-slightly-accelerating, no multibagger runway.
◆ Target entry zone$56 – $62accumulate in this band; ideal adds on a dip toward the 50-day average near $56, keeping roughly a 9% margin below our $68 base-case fair value⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 5%/yrTo justify today’s $62, earnings would have to compound roughly 5% a year for 10 years (9% discount rate). Analysts forecast ~3%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
U.S. Bancorp is one of the biggest "regular" banks in America — checking and savings accounts, credit cards, business loans, wealth management, and a large payments-processing arm. It is the kind of bank a nurse or a gas-station worker uses every day, headquartered in Minneapolis.
Is the stock cheap or expensive? Cheap. You are paying about 13 dollars for every 1 dollar of yearly profit — well below the stock market average — and you collect a 3.4% dividend (like interest) while you wait. The catch with cheap banks is that they are cheap for a reason: banks make money on the gap between what they charge borrowers and pay savers, and that gap shrinks or widens with interest rates and the economy. In a recession, more loans go bad.
Our verdict is Buy — Tactical: a fair-value, income-paying holding you buy for the dividend and a modest recovery in the share price, not a stock that will double quickly.
Here's what our three scores mean in everyday terms:
Downside Risk 4/10 (fairly safe, not bulletproof). Strong capital (a thick safety cushion regulators watch, called CET1, at 10.8%) and a cheap price limit the downside — but it's still a bank, so a bad economy hurts it.
Growth Quality 5/10 (solid, middle of the road). It's well-run and profitable, but it grows slowly — think low-to-mid single digits a year, helped by cost cuts.
Exponential Potential 2/10 (low). It's a giant, mature bank. Don't expect fireworks; expect a steady payer.
The one big worry: a recession or a downturn in commercial real estate would force the bank to set aside more money for loans that won't be repaid, cutting profits — and lower interest rates would squeeze the margin it earns on lending.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLF (sector)), set to 100 a year ago
Solid = USB · dashed = S&P 500 · dotted = XLF (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$61.73
Market cap$96B
P/E trailing3×
P/E FY26E / FY27E12× / 11×
EV / Sales2.9×
EV / EBITDA12.0×
Gross margin62.8%
Net margin18.0%
Dividend yield3.37%
Beta0.999
52-wk range$44 – $62
RSI(14)68
50 / 200-DMA$56 / $53
12-mo return+33% (SPY +21%)
Street target$64 ($60–$73)
Analyst grades22 Buy · 23 Hold · 3 Sell
FMP ratingA-
Next earnings2026-08-05
What the experts actually said 0 traceable claims on USB · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
U.S. Bancorp (NYSE: USB) is the parent of U.S. Bank, the fifth-largest commercial bank in the United States, founded in 1863 and headquartered in Minneapolis. It is a diversified super-regional with ~$692B in total assets, ~70,000 employees, and a branch/ATM network concentrated in the Midwest and West. The franchise spans five reported businesses: Consumer & Business Banking, Corporate & Commercial Banking, Wealth Management & Investment Services, Payment Services (a differentiated, fee-rich card/merchant-processing arm), and Treasury & Corporate Support. Fiscal year ends December 31. CEO is Gunjan Kedia.
Two structural features matter. First, USB's Payment Services segment gives it a higher fee-income mix than a plain-vanilla lender — a source of non-interest revenue that is less rate-sensitive. Second, the 2022–23 acquisition of MUFG Union Bank scaled its West Coast presence (and is why revenue optically jumped from $27B in FY22 to $40B+ from FY23 on).
Revenue mix (FY2025 product segmentation, from filings):
Wealth Management & Investment Services ~$12.1B · Payment Services ~$9.7B · Consumer & Small Business Banking ~$8.9B. (FMP's segment tags shift year to year and don't cleanly sum to total net revenue; treat these as directional. Note that on a bank's own "net revenue" basis — net interest income plus fee income — Q1'26 net revenue was $7.29B, i.e. ~$29–30B annualized, versus the ~$42.9B "revenue" line FMP reports, which grosses up interest income. §5 and §6 use the appropriate base for each ratio.)
By geography: essentially entirely United States; USB is a domestic bank with negligible non-US revenue.
The strategic story management keeps selling is operating leverage: grow fee income and priority loan categories (commercial, credit card) while holding expenses roughly flat, so revenue growth drops to the bottom line.
2. The expert thesis — why the panel is bullish (traceable)
There is none to cite. The Synthos knowledge base contains 0 claims on USB and 0 net-bullish (or bearish) expert voices. No fund manager, podcast, or analyst in our tracked universe has said anything about U.S. Bancorp that we can reconcile to a claim_id.
Per House Standard, this is stated plainly rather than papered over: this verdict is entirely fundamentals- and quant-driven. We are not borrowing conviction we do not have. The absence of expert coverage is itself information — USB is a well-understood, widely-held large-cap bank that generates no differentiated edge in our expert panel, and it should be sized and underwritten accordingly (a value/income satellite, §12). Everything below rests on the FMP financials, the analyst-estimate consensus (labeled as estimates), management's own SEC-filed earnings release (half-weighted, §9), and Synthos's own scoring model.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
4 · Moderate-Low
Cheap (~13× EPS, 1.46× book), A- rated, CET1 10.8%, beta ~1.0, tiny recent drawdown (−2.4% from peak). Offsetting: bank cyclicality, rate sensitivity, and CRE/credit exposure keep it from scoring lower.
Growth Quality
5 · Solid
~11% forward EPS CAGR (FY25 $4.61 → FY28E $6.31), 17% ROTCE, improving 58.2% efficiency ratio — but low-single-digit net-revenue growth and a mature, deposit-funded model cap the quality.
Exponential Potential
2 · Low
A $96B mature money-center bank. Growth is steady with a mild positive tilt (self-help + loan growth), but there is no acceleration and no room-to-run TAM story. Durable, not exponential.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Soft landing; NIM expands past 2.8%; loan growth mid-single-digit; efficiency ratio breaks below 56%; buybacks resume at scale. FY27E EPS beats to ~$6.10; the market re-rates a clean super-regional to ~13.5×.
~$82 (+33%)
Base(our anchor)
Estimates roughly hit — FY27E EPS $5.69; steady operating leverage; a re-rating from ~11× toward ~12× as rate/credit fears fade.
~$68 (+10%)
Bear
Recession + CRE deterioration; provisions spike, NIM compresses on rate cuts; EPS misses to ~$4.60 and the multiple de-rates to ~10× on credit fear.
~$46 (−25%)
Synthos fair value = the base case, ~$68 (+10%), with the full $46–$82 span as the honest range. This anchor sits modestly above the Street's $64.09 consensus — we give a touch more credit to the operating-leverage re-rating — while our bear ($46) is well below the Street's $60 low, because we take the credit/rate downside seriously for a cyclical lender. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). USB is neither an exponential nor even a fast compounder — it is a mature, cyclical value/income holding:
Forward growth: EPS CAGR FY25→FY28E ~11.0% ($4.61 → $6.31), but much of that is cost-out and buyback math, not top-line expansion. On the bank's own net-revenue base, growth is low-single-digit (Q1'26 net revenue +4.7% YoY, of which NII +4.1% and fees +6.9%).
Acceleration (the 2nd derivative): mildly positive but modest. EPS is re-accelerating off the post-MUFG-integration trough (FY24 $3.79 → FY25 $4.61 → FY26E $5.10 → FY27E $5.69), and Q1'26 delivered 440bps of positive operating leverage. This is a recovery/self-help acceleration, not a secular one — it fades as the efficiency story matures.
Room to run: effectively none in the exponential sense. At $96B market cap USB is already a top-5 US bank; the US banking "TAM" is mature, share gains are incremental, and regulation caps balance-sheet growth. A 5× from here is not a realistic scenario.
Reinvestment runway: limited — a bank returns capital (dividend 3.4%, buybacks) rather than reinvesting at high incremental ROIC. ROTCE ~17% is good but not a reinvestment-compounder profile.
Exponential Potential: Low (2/10). Own USB for a cheap multiple + 3.4% yield + a modest operating-leverage re-rating, not for growth. This honest framing is why USB belongs in a value/income satellite sleeve, not a growth-core or degen sleeve.
Banks don't map cleanly onto industrial income-statement lines. Where FMP's "revenue" grosses up total interest income (~$42.9B FY25), the more meaningful figure is management's net revenue = net interest income + fee income. Both are shown so ratios use the right base.
Net revenue (bank basis): Q1'26 $7.29B, +4.7% YoY (NII $4.29B taxable-equiv +4.1%; fee income $3.0B +6.9%). Roughly ~$29–30B annualized.
Net income: FY25 $7.58B (attributable), up from FY24 $6.30B and FY23 $5.43B — a clear post-integration recovery. Q1'26 net income $1.945B, +13.8% YoY.
Profitability: ROTCE 17.0%, ROA 1.15%, ROE ~12.2% TTM, net margin ~18% TTM. Efficiency ratio 58.2% (improved 260bps YoY) — the core self-help metric.
Capital & credit:CET1 10.8%, comfortably above requirement; net charge-off ratio 0.56% (stable); provision for credit losses $576M in Q1'26 (up 7.3% YoY, mostly on loan growth, not deterioration). Book value/share $37.93; tangible book value/share $29.56 (both rising YoY).
Balance sheet: total assets $692B; average deposits $515B (+1.7% YoY); average loans $394B (+3.8% YoY). Deposit-funded, investment-grade (issuer rating context: FMP letter grade A-).
Capital return: dividend $2.08/yr (raised to $0.52/quarter), 3.4% yield, payout ~45% — well-covered. Buybacks have been modest (net repurchase ~$0.49B FY25) as capital was rebuilt post-MUFG.
6. Valuation — priced in or room?
USB is cheap on every earnings-based lens, which is the heart of the value case:
P/E: ~13.4× trailing (FY25 $4.61) — FMP's TTM method shows 12.9×. Forward: 12.1× FY26E ($5.10) · 10.8× FY27E ($5.69) · 9.8× FY28E ($6.31). The multiple compresses toward single digits even at a flat price if estimates hit.
Book-value lenses (the right ones for a bank):P/B 1.46×, P/TBV ~2.0× ($61.73 / $29.56 TBVPS). For a bank earning a 17% ROTCE, ~2× tangible book is fair-to-slightly-cheap, not expensive.
Yield: 3.4% dividend, ~45% payout — you're paid to wait.
The bull's defense is not that USB is a hidden growth stock; it's that a clean, A-rated super-regional earning 17% ROTCE should not trade at ~11× forward once rate-cut and CRE fears normalize — a re-rating toward ~12–13.5× plus mid-single-digit EPS growth and the dividend is the return. Street targets (context): consensus $64.09, high $73, low $60, median $63; the analyst tape is a Hold (1 Strong Buy / 22 Buy / 23 Hold / 3 Sell) — i.e., the Street sees it as fairly valued, and our $68 base sits just above that. Not a deep-value screaming buy; a reasonably-priced quality bank with a re-rating option.
7. Technicals (from the FMP tech block)
Trend:up. $61.73 sits above the 50-DMA ($56.45) and 200-DMA ($53.20), with the 50 above the 200 (golden-cross posture). MACD +1.64 (positive).
Location: essentially at the 52-week high ($61.96, −0.4% off), +40% off the 52-week low ($43.94) — a name pushing new highs with a tiny max drawdown (−2.4% from peak).
Momentum: RSI(14) 68 — strong and approaching overbought (>70). This is the one caution flag: the entry is not a low; a pullback toward the rising 50-DMA (~$56) would be a lower-risk add.
Relative strength: USB +32.8% 12-mo vs SPY +20.6% (and vs QQQ +30.3%); +17.0% 3-mo vs SPY +13.7%. Outperforming the market over the past year — the recovery is being recognized.
Read: technicals confirm the fundamental recovery thesis, but with RSI near 70 the risk/reward on a fresh full-size entry is worse than it was; scale in, and prefer adds on weakness.
8. Moat & competitive position
USB's moat is a regulated-scale, low-cost-deposit franchise plus a differentiated Payment Services arm. The competitive edges: (1) a large, sticky, low-cost deposit base ($515B) that funds lending cheaply; (2) a fee-rich payments/merchant-acquiring business that most regional peers lack, lifting non-interest income and softening rate sensitivity; (3) scale efficiencies (58.2% efficiency ratio, improving) and a national brand. The limits: banking is a commoditized, heavily-regulated, cyclical business; switching costs are real but not absolute; and USB competes against both larger money-center banks (JPMorgan, Bank of America) with bigger tech budgets and nimble fintechs on the payments side. Recently announced partnerships (Amazon small-business cards, an NFL banking/wealth sponsorship) are incremental distribution wins, not moat-changers.
Peer set (FMP-supplied, market cap): PNC Financial $100B and Truist $64B are the closest US super-regional comps; the rest of the FMP list are foreign/global banks — Barclays $94B, Deutsche Bank $69B, ING $92B, Lloyds $88B, Mizuho $121B, HDFC $132B, Itaú $89B, CIBC $106B. Against US super-regional peers PNC and TFC, USB screens as similarly cheap with a stronger fee/payments mix and a comparable ~17% ROTCE.
9. Management, capital allocation & guidance
Capital allocation: conservative and shareholder-friendly — rebuild capital first (CET1 to 10.8%), pay a growing, well-covered dividend (3.4% yield, ~45% payout), and buy back stock modestly as capital permits. Appropriate for a post-acquisition bank; not aggressive.
Insider activity: the sampled window shows routine director stock/RSU awards (April 2026) and one officer open-market sale (Chief Info & Tech Officer, ~34.5k shares at $55.52 on 2026-05-05) — normal compensation-driven diversification, no alarming cluster of discretionary selling.
Management's own guidance (SEC 8-K, Item 2.02 — half-weighted, they talk their book): USB's Q1'26 earnings release (filed 2026-04-16) reads as a genuine release (revenue, margins, capital, CEO commentary). Management's self-interested framing: Q1'26 diluted EPS $1.18, +15% YoY; ROTCE 17%; 440bps of positive operating leverage; 260bps YoY efficiency-ratio improvement; NII +4.1% and fee revenue +6.9% YoY; NIM up to 2.77%; CET1 10.8%. CEO Gunjan Kedia states results were "within our medium-term financial target ranges" with "strong momentum across the franchise," citing the new Amazon and NFL partnerships. Treat as management's own words at half weight — the direction (operating leverage, fee momentum, stable credit) is corroborated by the reported financials, but no explicit full-year numeric revenue/EPS guide was provided in the release we pulled.
10. Catalysts & what to watch
Next earnings: 2026-07-16 (Q2'26; Street EPS $1.27, revenue est ~$7.55B). The key lines: NIM direction, fee-income momentum (payments, capital markets), efficiency ratio, and provision/charge-off trend.
Rate path: the Fed's rate trajectory drives NIM — cuts pressure asset yields but can lift deposit-cost relief; the net is the swing factor for NII.
Credit & CRE: net charge-off ratio and CRE reserve build — the primary downside tripwire for any regional bank.
Operating leverage: whether management sustains positive operating leverage and pushes the efficiency ratio below ~56% (bull-case trigger).
Capital return: post-stress-test buyback authorization — a resumption of scale repurchases would support EPS and signal capital confidence.
Thesis tripwires (what would change the call): two consecutive quarters of negative operating leverage; a sharp CRE-driven jump in charge-offs above ~0.8%; NIM compression back below ~2.6%; or a CET1 slip that halts buybacks.
11. Key risks
Rate-cycle & NIM (structural for banks): net interest income is ~60% of revenue; a wrong-way rate move or an inverted/flattening curve compresses the margin.
Credit / CRE: provisions rose 7.3% YoY (loan growth today, but a recession flips that to genuine deterioration); commercial real-estate exposure is the sector-wide watch item.
Cyclicality: beta ~1.0 and a loan book tied to the US economy — earnings fall in a downturn, unlike a defensive compounder.
Regulation & capital: stress-test outcomes, Basel III endgame, and any CET1 requirement changes can constrain buybacks and returns.
No expert edge: the honest one — zero Synthos KB coverage means no differentiated informational advantage here; this is a data-and-valuation call, sized as a satellite, not a conviction core.
RSI near overbought: the entry is near a 52-week high with RSI ~68 — near-term pullback risk on a full-size entry.
12. Verdict, position sizing & monitoring
Buy — Tactical. USB is a cheap (~13× trailing, ~11× forward, ~2× tangible book), A-rated super-regional earning a 17% ROTCE, paying a well-covered 3.4% dividend, with a real self-help operating-leverage story (58.2% efficiency ratio, 440bps positive operating leverage, +15% YoY EPS in Q1'26) and momentum confirmed by both fundamentals and the tape. The return case is a valuation re-rating (~11× → ~12–13×) plus mid-single-digit compounding plus the yield — a solid ~10%+ base-case total return, not a growth story. It is explicitly not a conviction-core name: no Synthos expert covers it, so it earns a tactical, data-driven rating and a satellite-sized position.
Sizing: value/income satellite, ~1.5–3%. With RSI near 70, scale in (starter now, adds toward the rising 50-DMA ~$56) rather than a single lump.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print (next 2026-07-16). This verdict is logged as a tracked Synthos call as of 2026-07-03 at $61.73.
Single biggest risk: the rate/credit cycle — a recession or CRE deterioration lifts provisions and compresses NIM, and USB is a cyclical lender, not a defensive compounder.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — there is no expert coverage of USB in the Synthos knowledge base, and no claim_id is cited because none exists. This verdict is fundamentals- and quant-driven, and is labeled as such. Fabricated conviction is structurally impossible (claim-ID reconciliation).
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-03 · management guidance from the SEC 8-K earnings release filed 2026-04-16. Forward figures are analyst consensus (FMP), labeled as estimates.
Bank-accounting caveat: FMP's "revenue" line grosses up total interest income; ratios in §5–§6 use the appropriate net-revenue or book-value base where relevant. Segment tags from FMP are directional only.
Management caveat: the Q1'26 earnings-release figures in §9 are management's own, half-weighted by design.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").